From Casetext: Smarter Legal Research

In re Generic Pharm. Pricing Antitrust Litig.

United States District Court, E.D. Pennsylvania
Jun 7, 2022
MDL 2724 (E.D. Pa. Jun. 7, 2022)

Opinion

MDL 2724 16-MD-2724

06-07-2022

IN RE GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION THIS DOCUMENT RELATES TO In re State Attorneys General Litigation No. 17-3768


CYNTHIA M. RUFE, Judge

ORDER

CYNTHIA M. RUFE, Judge

AND NOW, this 7th day of June 2022, upon consideration of Defendants' Joint Motion to Dismiss Plaintiffs' Federal Law Claims for Lack of Standing [Doc. No. 74] and the responses, replies, and notices of supplemental authority, it is hereby ORDERED that:

1. Defendants' Motion to Dismiss is GRANTED to the extent that it seeks dismissal of Plaintiffs' claims for disgorgement under § 16 of the Clayton Act; and

2. The Motion is DENIED to the extent that it seeks dismissal of Plaintiffs' federal claims for injunctive relief as parens patriae under federal law.

It is so ORDERED.

Summaries of

In re Generic Pharm. Pricing Antitrust Litig.

United States District Court, E.D. Pennsylvania
Jun 7, 2022
MDL 2724 (E.D. Pa. Jun. 7, 2022)
Case details for

In re Generic Pharm. Pricing Antitrust Litig.

Case Details

Full title:IN RE GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION THIS DOCUMENT…

Court:United States District Court, E.D. Pennsylvania

Date published: Jun 7, 2022

Citations

MDL 2724 (E.D. Pa. Jun. 7, 2022)